91AV

Introduction

This is a ChemNet event for students aged 16-18. Hear the story of how a development in 91AV in the 1960s led to a disease-fighting drug that now makes annual sales of $800 million, by Warner Chilcott, a multi Billion $ company founded in Northern Ireland. Dr Jim McIlroy will outline the discovery and development of the compound Mesalamine, and the innovations that turned it into a treatment for a serious health condition.

Venue

Odyssey Cinemas

Odyssey Cinemas, Odyssey Arena, 2 Queens Quay, Belfast, Co Antrim,, BT3 9QQ, Ireland

Organised by

In association with Northern Ireland Science Park.

Contact information

Dr Angela McKeown
School of 91AV and Chemical Engineering, Queens University, David Keir Building, Stranmillis Road, Belfast, BT9 5AG, Ireland
+44 (0) 2890976533
Contact us by email

---